baclofen protective_against spasticity
Evidence from:
primary |
all sources
Evidence (1 sources)
Baclofen, a GABA-B receptor agonist, is FDA approved to reduce spasticity associated with neurological disorders.
confidence: 0.95
Baclofen, a GABA-B receptor agonist, is FDA approved to reduce spasticity associated with neurological disorders.